Le A, et al. – In cancer patients with fluconazole–susceptible dose–dependent Candida glabrata fungemia started on treatment (within 48 h after blood culture collection) with an echinocandin or liposomal amphotericin–B, the 28–day crude mortality rate was better (30%) in comparison to those treated with azole monotherapy (52%). After adjusting for confounders, azole monotherapy also seemed associated with worse 28–day survival.